Literature DB >> 13981612

Metabolism of thiopyrimidines and thiopurines. S-Methylation with S-adenosylmethionine transmethylase and catabolism in mammalian tissues.

C N REMY.   

Abstract

Entities:  

Keywords:  PURINES; PYRIMIDINES; TRANSFERASES

Mesh：

Substances：

Year:  1963        PMID： 13981612

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  20 in total

1.  Human thiopurine S-methyltransferase pharmacogenetics: variant allozyme misfolding and aggresome formation.

Authors:  Liewei Wang; Tien V Nguyen; Richard W McLaughlin; Laura A Sikkink; Marina Ramirez-Alvarado; Richard M Weinshilboum
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-20       Impact factor: 11.205

Review 2.  Pharmacogenomics: catechol O-methyltransferase to thiopurine S-methyltransferase.

Authors:  Richard M Weinshilboum
Journal:  Cell Mol Neurobiol       Date:  2006-06-29       Impact factor: 5.046

3.  Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity.

Authors:  D M Otterness; C L Szumlanski; T C Wood; R M Weinshilboum
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

Review 4.  Pharmacogenetics as a molecular basis for individualized drug therapy: the thiopurine S-methyltransferase paradigm.

Authors:  E Y Krynetski; W E Evans
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

5.  Thiopurine methyltransferase biochemical genetics: human lymphocyte activity.

Authors:  J A Van Loon; R M Weinshilboum
Journal:  Biochem Genet       Date:  1982-08       Impact factor: 1.890

6.  Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine.

Authors:  C L Szumlanski; R M Weinshilboum
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

7.  Thiopurine S-methyltransferase pharmacogenetics: autophagy as a mechanism for variant allozyme degradation.

Authors:  Fang Li; Liewei Wang; Rebecca J Burgess; Richard M Weinshilboum
Journal:  Pharmacogenet Genomics       Date:  2008-12       Impact factor: 2.089

8.  Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.

Authors:  R M Weinshilboum; S L Sladek
Journal:  Am J Hum Genet       Date:  1980-09       Impact factor: 11.025

9.  Pharmacogenetics of human erythrocyte thiopurine methyltransferase activity in a French population.

Authors:  M Tinel; A Berson; D Pessayre; P Letteron; M P Cattoni; Y Horsmans; D Larrey
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

10.  Decrease in S-adenosylmethionine synthesis by 6-mercaptopurine and methylmercaptopurine ribonucleoside in Molt F4 human malignant lymphoblasts.

Authors:  E H Stet; R A De Abreu; J P Bökkerink; H J Blom; L H Lambooy; T M Vogels-Mentink; A C de Graaf-Hess; B van Raay-Selten; F J Trijbels
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.